Erdoğan Selçuk Şeber

6PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersMolecular targetsTumour immunologyObstetrics and gynaecologyChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 15, 2026
Independent prognostic ımpact of perineural ınvasion in breast cancer patients with residual disease after neoadjuvant chemotherapy.

|Oct 22, 2025
Expression of gamma-aminobutyric acid type A receptor subunit π and minichromosome maintenance-3 in breast cancer patients treated with neoadjuvant chemotherapy: a target molecule or a proliferation marker?

Yakup İriagac, Meltem Oznur, Eyyup Çavdar

|Oct 01, 2025
The role of peripheral T lymphocyte subsets and PD-1 expression as a biomarker for neoadjuvant treatment response in breast cancer.

Tarkan Yetişyiğit, Kubilay Karaboyun, Yakup İriağaç

|May 10, 2023
Tamoxifen or aromatase inhibitors: which one is the culprit of urinary incontinence in premenopausal breast cancer patients receiving adjuvant hormone therapy?

Kubilay Karaboyun, Eyyup Cavdar, Yakup Irıagac

|Mar 15, 2023
A logarithmic model for hormone receptor-positive and breast cancer patients treated with neoadjuvant chemotherapy.

Erdoğan Selçuk Şeber, Yakup İriagac, Eyyup Çavdar

|Jan 30, 2022
The influence of visual objects and music on anxiety levels of breast cancer patients scheduled to experience chemotherapy for the first time: a prospective randomized clinical study.

Yakup İriağaç, Eyyüp Çavdar, Kubilay Karaboyun

Pageof 1

Frequent Collaborators

6 joint publications

Eyyüp Çavdar

5 joint publications

Yakup Irıagac

5 joint publications

Kubilay Karaboyun

5 joint publications

Okan Avcı